Skip to content

    Statistically significant and clinically meaningful are different questions

    Statistically significant and clinically meaningful are different questions

    “The results were statistically significant” sounds like a strong ending to a health story. But it leaves an important question unanswered: was the difference large enough to matter to the people receiving the treatment?

    Statistical significance and clinical meaningfulness are related, but they aren't synonyms. One concerns the strength of statistical evidence under a model and chosen threshold. The other asks about the practical importance of the result, including benefits, downsides and the priorities of the person considering care.

    A tiny difference can be measured precisely

    Imagine a fictional study with many participants. On a 100-point symptom scale, one group improves by an average of 0.3 points more than another. Suppose the estimate is precise enough to meet the study's threshold for statistical significance.

    That result may provide evidence of a difference between the groups. It doesn't automatically tell you that a 0.3-point change is noticeable or worthwhile in daily life. To answer that, you'd need to understand the scale, the people studied and what size of change patients consider important.

    Now imagine the treatment also requires frequent appointments or causes side effects. Those burdens belong in the decision too. A statistically detectable difference can be real and still be too small, for a particular person, to justify the tradeoff.

    The example is invented to show the distinction; it isn't a claim about a specific weight-loss medicine or symptom scale.

    A meaningful-looking result can still be uncertain

    Consider another fictional study. The average difference is seven points, but the confidence interval ranges from one point worse to 15 points better. That range includes possibilities that would lead to very different conclusions. The central estimate may look promising, yet the study leaves substantial uncertainty about the size and even direction of the effect.

    It would be a mistake to call the treatment ineffective merely because that result doesn't cross a conventional significance threshold. It would also be a mistake to promise a seven-point benefit. The sensible response is to examine the interval, the study design and the rest of the evidence.

    These examples show why a yes-or-no label is rarely the whole story. Ask how big the estimated difference was and how precise the estimate was.

    Who decides what matters?

    Researchers may use a prespecified threshold or established measure to judge whether a change is clinically important. Clinicians and patients also consider what the outcome means in daily life. A change in a laboratory number, a symptom score and the ability to carry out a valued activity are different kinds of outcomes.

    People can reasonably weigh the same result differently. Someone bothered by a particular symptom may value a modest improvement, while someone else may not consider it worth the cost, inconvenience or side effects. The average from a study doesn't guarantee the same experience for every individual.

    Ask what the outcome measured, how it was measured and over what period. If the result is a percentage, find out whether it refers to a relative change or the actual difference in the number of people affected. Those can sound very different in a headline.

    Look beyond the p-value

    A p-value is a statistical measure calculated under a specified model and assumptions. It isn't the probability that the treatment works, the chance that the result will apply to you or a measure of how important the effect is. A result just below a chosen cutoff isn't automatically more useful than a similar result just above it.

    Look for the effect estimate and confidence interval, then consider study quality. Were participants assigned to groups appropriately? Was the outcome defined in advance? How many people completed follow-up? Were harms and benefits both reported? A precise estimate from a poorly designed study can still mislead.

    One study also sits within a larger body of evidence. Other well-designed studies may support the finding, show a different effect or reveal limits that the first report couldn't address.

    Pay attention to the comparison group as well. A treatment might be compared with an inactive treatment, usual care or another active option. Knowing the comparison helps you understand what the reported difference actually represents and which choice it can inform.

    Bring the question back to your care

    When discussing a treatment, try: “How much difference did the study find, how sure are we about that amount, and what might it mean for someone with my health history?” Ask about the time horizon, possible adverse effects, cost and alternatives, including continuing the current plan when appropriate.

    If a clinician says the evidence is uncertain, ask what that uncertainty changes about the decision and what follow-up would help. You don't need to settle a statistical debate in the exam room. You do deserve an explanation of the expected benefits and tradeoffs in terms that connect to your priorities.

    A significant result can be useful evidence. Whether it is meaningful for your life is a further question—and a good one to ask.